RU-486

RU-486

The Food and Drug Administration's approval of the abortion drug RU-486 sparked a new round of debate between pro-life and pro-choice activists, but it also brought forth a new discussion about the drug's medical benefits and drawbacks...

The Food and Drug Administration's approval of the abortion drug RU-486 sparked a new round of debate between pro-life and pro-choice activists, but it also brought forth a new discussion about the drug's medical benefits and drawbacks, who will be allowed to administer it, and how states will regulate its use. A panel talks about the new concerns raised by the introduction of RU-486 in the U.S.

Guests

Maxine Klane

Planned Parenthood of Metropolitan Washington

Dr. Mitchell Creinin

physician

Richard Pierce

professor of administrative law at George Washington University

Please familiarize yourself with our Code of Conduct and Terms of Use before posting your comments.

Our address has changed!

The Diane Rehm Show is produced by member-supported WAMU 88.5 in Washington DC.